Marcus Jonathan L's Form 4 filing
CME Group Inc.CME · filed Mar 19, 2026
- Accession no.
- 0001628280-26-019658
- Filed
- Mar 19, 2026
- Trade date
- Mar 17, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $1.10M. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001628280-26-020364 (Mar 23, 2026). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Marcus Jonathan LCIK 0001952996 | Officer (Sr MD General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Common Stock Class A | SSaleDisposed | −3,291 | $333.37 | −$1,097,120.67 | 7,192 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.